- Published at
- by etfdailynews.com
positive
positive
Lions Bay Mining (OTCMKTS:LMNGF) Trading Down 23.5%
Read Lions Bay Mining (OTCMKTS:LMNGF) Trading Down 23.5% at ETF Daily News
News for Lions Bay Mining Corp. (LMNGF)
- Published at
- by etfdailynews.com
positivepositiveLions Bay Mining (OTCMKTS:LMNGF) Shares Up 66.7%
Read Lions Bay Mining (OTCMKTS:LMNGF) Shares Up 66.7% at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveLions Bay Mining (OTCMKTS:LMNGF) Stock Price Up 5.8%
Read Lions Bay Mining (OTCMKTS:LMNGF) Stock Price Up 5.8% at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveLions Bay Mining (OTCMKTS:LMNGF) Trading 43.3% Higher
Read Lions Bay Mining (OTCMKTS:LMNGF) Trading 43.3% Higher at ETF Daily News- Published at
- by prnewswire.com
mixedmixedBioVaxys et BioElpida signent un accord d'exclusivité définitif pour lancer la bioproduction d'un vaccin contre le cancer de l'ovaire
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (CSE: BIOV.CN) (FRA: 5LB) (OTC: BVAXF) (« BioVaxys » ou la « Société ») a annoncé aujourd'hui la...- Published at
- by prnewswire.com
mixedmixedBioVaxys erweitert Patent-Portfolio und reicht gewerbliche Markenanmeldung für CoviDTH®-Test ein
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: BVAXF) („BioVaxys" oder „das Unternehmen"), der weltweit führende Anbieter von...- Published at
- by prnewswire.com
mixedmixedBioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH® Diagnostic
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: BVAXF) ("BioVaxys" or "the Company"), the world leader in haptenized antigen vaccines...- Published at
- by prnewswire.com
negativenegativeBioVaxys élargit son portefeuille de propriété intellectuelle
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) (« BioVaxys » ou « la Société »), leader mondial des vaccins à antigènes...- Published at
- by prnewswire.com
mixedmixedThanks to Accelerated COVID-19 Research, New Therapeutic Vaccines May Soon Be Upon Us
/PRNewswire/ -- USA News Group - Rollouts of two approved COVID-19 vaccines have for the past few months started making their way into markets around the world....- Published at
- by marketscreener.com
mixedmixedAs Additional COVID Variants Surface, Questions Arise to Effectiveness of Vaccines to Combat New Strains
with mutations in the spike protein have been spreading globally and appear to cause?major changes in the way the virus acts, including enhanced transmissibility and possibly increased clinical...- Published at
- by prnewswire.com
negativenegativeBioVaxys und BioElpida unterzeichnen Termsheet für die Bioproduktion von BVX-0918A unter klinischen Anforderungen
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) („BioVaxys" oder „Unternehmen") gab heute bekannt, dass es ein Termsheet...- Published at
- by prnewswire.com
mixedmixedBioVaxys et BioElpida signent une liste de conditions pour la bioproduction de qualité clinique du BVX-0918A
/PRNewswire/ -- BioVaxys Technology Corp. (CSE : BIOV) (FRA : 5LB) (OTC : LMNGF) (« BioVaxys » ou la « Société ») a annoncé aujourd'hui avoir signé une liste...- Published at
- by prnewswire.com
neutralneutralBioVaxys y BioElpida firman un acuerdo de términos
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" o "la compañía") ha anunciado hoy la firma de un acuerdo de términos...- Published at
- by prnewswire.com
mixedmixedBioVaxys und Procare Health geben umfassende Zusammenarbeit bei der Entwicklung, gemeinsamen Vermarktung und dem Marketing von Krebs- und Virusimpfstoffen bekannt
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC:L MNGF) („BioVaxys"), der weltweit führende Hersteller von haptenisierten...- Published at
- by prnewswire.com
mixedmixedBioVaxys et Procare Health annoncent une vaste collaboration pour le développement, la commercialisation et le marketing de vaccins contre le cancer et de vaccins antiviraux
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC:L MNGF) (« BioVaxys »), le leader mondial de vaccins à base de protéines hapténisées pour...- Published at
- by prnewswire.com
mixedmixedImmunotherapy Using Immune-Checkpoint Inhibitors (ICI) Modulators Are Revolutionizing Oncology Industry
/PRNewswire/ -- Ovarian cancer is one of the most deadly gynecologic malignancy across the globe, but new treatments are gaining increased efficacy while...